CMV Screening Tool
Cytomegalovirus risk assessment for immunocompromised patients
Professional-grade screening tool to evaluate CMV symptoms and risk factors, particularly designed for immunocompromised individuals including HIV patients and transplant recipients. Get personalized recommendations for serology testing and medical consultation.
CMV Risk Assessment
Ready to Begin CMV Screening
Click "Start Assessment" to begin the confidential health evaluation
This assessment takes approximately 4-6 minutes to complete
🔬 Specialized for immunocompromised patients and high-risk populations
Assessment Results
Complete Assessment to View Results
Your personalized CMV risk assessment and recommendations will appear here
When to Use CMV Screening Tool
HIV Patients with Symptoms
If you have HIV and experience fever, fatigue, vision changes, or respiratory symptoms that could indicate CMV reactivation or new infection.
Transplant Recipients
For organ or stem cell transplant recipients experiencing unexplained symptoms or as part of routine CMV monitoring protocols.
Immunosuppressive Medications
Patients taking immunosuppressive drugs for autoimmune conditions who develop concerning symptoms that may indicate CMV infection.
Vision Problems
Immunocompromised patients experiencing vision changes, eye pain, or visual field defects that could indicate CMV retinitis.
Pre-Transplant Screening
Before organ or stem cell transplantation to assess CMV serology status and plan appropriate prophylaxis strategies.
Educational Assessment
Healthcare professionals and patients learning about CMV risk factors, symptoms, and the importance of early detection in vulnerable populations.
Frequently Asked Questions
What is the CMV Screening Tool?
Our CMV screening tool is a comprehensive assessment that evaluates symptoms, immune status, and risk factors to help determine if cytomegalovirus testing is recommended. It's particularly designed for immunocompromised patients including HIV patients, transplant recipients, and those on immunosuppressive medications.
Who should use this CMV screening tool?
This tool is especially valuable for immunocompromised individuals including HIV patients with low CD4 counts, organ transplant recipients, stem cell transplant patients, those on immunosuppressive medications, and patients with unexplained symptoms that could indicate CMV infection.
What CMV symptoms does this tool evaluate?
The assessment evaluates fever, prolonged fatigue, muscle aches, swollen lymph nodes, vision problems, respiratory symptoms, gastrointestinal issues, and neurological symptoms. It also considers specific manifestations like CMV retinitis, pneumonitis, and gastrointestinal disease.
Is CMV dangerous for immunocompromised patients?
Yes, CMV can cause serious life-threatening complications in immunocompromised patients including pneumonia, retinitis leading to blindness, gastrointestinal disease, encephalitis, and organ rejection in transplant recipients. Early detection and treatment are crucial for preventing severe outcomes.
What is CMV serology testing?
CMV serology testing measures IgG and IgM antibodies in blood to determine past exposure and current infection status. IgG indicates past infection or immunity, while IgM suggests recent or active infection. This testing is essential for risk assessment in transplant patients and immunocompromised individuals.
How accurate is this CMV assessment?
This tool provides educational risk assessment based on current medical guidelines and clinical evidence, but it cannot replace professional medical diagnosis. The assessment helps identify when professional CMV testing is recommended, but always consult healthcare providers for definitive testing and treatment.
When should immunocompromised patients get CMV testing?
Immunocompromised patients should consider CMV testing when experiencing unexplained fever, fatigue, vision changes, respiratory symptoms, or gastrointestinal issues. Regular monitoring may be recommended for high-risk patients, especially transplant recipients and those with advanced HIV disease.
Is my assessment information kept private?
Yes, all assessment data is processed locally in your browser and is not stored, transmitted, or shared with any servers or third parties. Your privacy and confidentiality are fully protected throughout the screening process. We do not collect or store any personal health information.
No comments yet. Be the first to share your thoughts!